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Simple Summary: Acute abdominal pain is a major cause for emergency treatment in horses and
associated with a high stress level leading to an increased serum cortisol concentration. Stress can
also be assessed by analyzing the heart rate variability (HRV). We investigated whether the stress
level was different between horses with different causes of abdominal pain and, therefore, demanding
a different treatment strategy. Heart rate, its variability in the time domain analyses, and cortisol
level indicated a decrease in the stress level the day after admission and the day of discharge from the
hospital in comparison to admission for both conservatively and surgically treated patients. However,
such changes, over time, were not seen in horses that were euthanized during the hospitalization.
Furthermore, the difference in the parameters measured between horses that were eventually
euthanized and those that survived was best visible the day after admission. Therefore, we concluded
that HRV can give further important information on the stress level in horses with colic and might be
helpful in assessing possible outcome. However, further studies are required to assess the validity of
HRV analyses in horses with colic.
Abstract: Heart rate variability (HRV) is a noninvasive technique to detect changes in the autonomous
nervous system. It has rarely been investigated in horses with colic. Therefore, the objective was to
assess the evolution of HRV parameters and cortisol concentrations in horses with colic. The 43 horses
included in this study were categorized into three groups according to the treatment (1, surgical;
2, conservative; 3, euthanized). The HRV and laboratory variables were measured at admission (T1),
the day after admission (T2), and at discharge (T3) and compared between groups and over time with
an ANOVA with Bonferroni correction. Relationships between the HRV parameters themselves and
the laboratory variables was assessed by Pearson correlation coefficients. Evolution of the heart rate
(HR) over time, mean normal to normal R intervals (meanNN) and cortisol concentrations indicate a
decreased sympathetic stimulation over time in group 1 and 2, in contrast to group 3. For group 3,
the meanNN and HR differed significantly to group 2 at T1 and to group 1 and 2 at T2. Treatment
induced a change in the HRV and cortisol response in horses managed conservatively or surgically
but not in horses that required euthanasia. However, further studies are required to assess the validity
of HRV analyses in horses with colic.
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1. Introduction
Acute abdominal pain (colic) caused by gastrointestinal tract diseases in horses represents a
frequent emergency in equine medicine and, depending on the cause of the colic, can be associated
with a guarded to poor prognosis [1,2]. The initial exam aims at triaging for therapeutic intervention.
However, time for the diagnosis and treatment is limited, especially when a surgical intervention is
indicated, due to the dynamic progression of the condition. Surgeries are often associated with higher
treatment expenses. Furthermore, the convalescence may take longer [3], and outcomes, survival rate,
and future use are affected [4,5]. Therefore, diagnostic tests or procedures helping in decision-making
as soon as possible after admission is needed. Available research in horses with acute gastrointestinal
diseases has focused on investigating laboratory diagnostic variables (e.g., tumor necrosis factor,
serum amyloid A, and plasma lactate). Regarding these variables, the goals were to assess the status of
the circulatory volume and the damage to the intestinal wall [6–10] to predict the need for surgery or
survival. The heart rate variability (HRV) has only rarely been used so far for this purpose [11].
Analysis of the HRV is a non-invasive technique to assess the activity of the autonomous nervous
system [12]. In human medicine, the HRV has shown diagnostic values in assessing the progression
of various diseases, for example survival after myocardial infarction [13] or neuropathy in diabetic
patients [14]. The HRV has been used in behavioral research in horses for investigating the reaction
of the autonomous nervous system to different stressful situations [15–17]. Furthermore, it has been
utilized to identify dysautonomia in equine grass sickness [18], to assess different pain conditions [19],
and to monitor the influence of special surgical investigations on the autonomous nervous system [20].
The analyses of the HRV can be done with two different approaches: the time domain analysis and
the frequency domain analysis. The time domain analysis is based on the mathematical analysis
of successive RR-intervals. Increasing variation in the successive RR intervals are related to high
parasympathetic activity. The frequency domain analysis is based on a power spectral analysis using a
fast Fourier transformation and the obtained power specters are decomposed in a high frequency (HF)
range and a low frequency (LF) range. The HF represents the parasympathetic activity, whereas the LF
and the LF/HF represents the sympathetic-vagal balance [21,22]. Even though the HRV analysis is
a noninvasive method to assess stress and painful conditions, studies in horses with signs of acute
abdominal pain are sparse [11]. The objective of the present study was to investigate the feasibility
of HRV analyses in horses with colic and to analyze the correlation between parameters of the HRV
analyses, serum cortisol concentrations, and the severity of the colic.
We hypothesized that horses with severe colic, in which a surgical intervention or euthanasia was
required, would have higher stress level, higher serum cortisol concentrations, and lower variation in
successive RR intervals translating in a reduction of the HRV variables of the time domain analysis and
a lower HF value than horses with milder colic treated conservatively without surgical intervention
and which survived. Moreover, we hypothesized that the HRV parameters of the time domain analyses
and the HF values would increase over time in conservatively treated cases and in surgically treated
cases that survived to discharge and would be equal in both groups on the day of discharge.
2. Materials and Methods
Study population—The data of 43 horses presented for acute abdominal pain (colic) in two
equine referral hospitals between February and July 2012 were included in this study. Breed, use, age,
and sex, as well as premedication (up to 2 h prior to arrival) and medication given after admission,
were recorded and included in the analysis.
Data collection—All horses included in the study underwent a complete physical examination
immediately after admission, focusing on the heart rate (HR), status of the circulatory volume and
abnormalities in the gastrointestinal system. Furthermore, blood analyses, including packed cell volume
(PCV), total protein (TP), and plasma lactate, rectal palpation, abdominal ultrasound, and passage
of the nasogastric tube were performed. The clinical exam was completed by an abdominocentesis
in 19 cases. The severity of colic pain was evaluated and graded as mild (low grade pain shown by
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pawing, flehmening, normal borborygmi, normal abdominal wall contour, mild distension at rectal
examination), moderate (moderate grade of pain shown by lying down, diminished borborygmi,
moderate distension of the abdominal wall contour, moderate distention at rectal examination),
and severe (severe pain, absent borborygmi, severe distension of the abdominal wall contour and
severe distention at rectal examination) [23]. An electrocardiogram (ECG) was recorded and the results
of the blood samples were analyzed for the following time points: Upon arrival (T1), and, if horses
were still alive or still in the hospital, between 9:00 a.m. and 11:00 a.m. on the day after the admission
(T2), as well as on the day of discharge (T3). The initial treatment was based on findings of the clinical
and laboratory examination and was adapted depending on case evolution by the clinician in charge,
independently of the sampling scheme. The horses in the study were then retrospectively assigned
to the following groups regarding the treatment applied or outcome: Group 1 = surgical, Group 2
= conservative, and Group 3 = euthanized (during hospitalization based on clinical worsening of
the condition, poor prognosis or financial concerns). Group 1 and 2 were, therefore, discharged,
and Group 3 represented the non-survivor group. Two horses were discharged on T2, and further
measurement time points are consequently missing. Postsurgical medication was administered at the
clinician’s discretion.
Blood samples analyzed in the present study were taken during routine puncture of the jugular
vein. The PCV was measured by microcentrifugation and TP was measured with a handheld
refractometer (HRM 18, 726000, Eickemeyer KG, Tuttlingen, Germany). The samples for plasma
lactate measurements were collected in calcium-lithium-heparintubes (Arterial blood collection syringe,
BD A-Line TM, 3 mL, Becton, Dickinson & Company, Plymouth, UK) and analyzed with a Cobas b 123
POC System (Roche Diagnostics Deutschland GmbH, Mannheim, Germany). The serum for the serum
cortisol measurements was collected in plain tubes (Sarstedt AG & Co. KG, Nümbrecht, Germany).
Subsequently, the samples were stored at −80 ◦C and later analyzed by high-performance liquid
chromatography in a commercial laboratory (Laboklin GmbH & Co.KG, Bad Kissingen, Germany).
According to the laboratory information, the analytic sensitivity was 2 ng/mL, the coefficient of variation
for intra-assay variability was 9.92% and 2.39%.for inter-assay variance
All blood samples were taken for the routine work-up of colic patients in the hospitals. The results
of the laboratory analyses (i.e., PCV, plasma lactate, TP) were used in the clinical work-up and in
decision-making regarding the treatment of the horses. The results of these analyses were only
statistically analyzed in the present study. The blood used for the cortisol analyses was leftovers from
the samples taken for the routine clinical work-up. Therefore, according to the German law, sampling
of horses affected by colic was not classified as animal experiments by the State Office of Health and
Social Affairs Berlin (Landesamt für Gesundheit und Soziales)
The ECG was a surface ECG with adhesive electrodes placed on the horses. Therefore, it is a
noninvasive procedure and according to the German law, was not classified as an animal experiments
by the State Office of Health and Social Affairs Berlin (Landesamt für Gesundheit und Soziales).
The ECG electrodes were placed on the horse in parallel to all the other examinations performed by a
separate person not involved in the clinical work-up (M.-D.F.). Therefore, the recording of the ECG
did not interfere or delay any of the decisions or procedures applied for the treatment of the horses
enrolled. Lastly, owners’ verbal consent to involve their horses in the study was obtained during the
admission process at both hospitals.
Analyses of the HRV—ECG recordings lasted 5 min (300 s) and were collected with a telemetric ECG
device (Televet-100 EKG, Engel Engineering, Heusenstamm, Germany). The device was attached to the
animal using four adhesive electrodes from which two were placed on the left chest wall at the elbow
level and on the left chest wall at the withers level, representing a modified base-apex lead position [24].
A bandpass filter of 50 Hz was applied to avoid signal interference. The errors in RR waves recognition,
arrythmias as supraventricular extrasystoles, associated with a compensatory shortened RR interval,
atrioventricular blocks, and artifacts were corrected or removed manually from the ECG [24,25] using
the dedicated software. The RR intervals were measured in milliseconds, exported from the reading
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software and imported into the HRV Analysis Software (HRV Analysis Software 2.0, Biosignal Analysis
& Medical Imaging Group, Physics Department, University of Kuopio, Kuopio, Finland). This software
allowed us to perform time and the frequency domain analyses. The time domain analysis is based
on the analyses of the inter-beat interval, which is the time period between consecutive heartbeats
(NN = Normal to Normal intervals). The parameters of the time domain analyses are the mean
normal-to-normal (beat-to-beat) interval (meanNN), the standard deviation of NN intervals (SDNN),
and percentage of consecutive RR intervals that differed more than 50 ms (pNN50). Moreover, HRV was
analyzed in the frequency domain based on power spectral analysis using a fast Fourier transformation.
The HRV parameters in the frequency domain were the high-frequency (HF) ranges, low-frequency
(LF) ranges, and the low-/high-frequency ratio (LF/HF). The HF power shows mainly the vagal activity,
whereas the LF power presented both vagal and sympathetic activity. The LF/HF ratio represented
the sympathetic-vagal balance [21,22]. The frequency component thresholds for LF were set at
0.005–0.07 Hz, as previously described [20–22,26–28]. The upper limit for HF was set at 1.0 Hz due to
the higher HF range in horses which is related to their respiratory rate, which might reached 60/min
in some horses (personal communication with the Kubios HRV software engineer and suggested by
Cottin et al. [29] and Rietmann et al. [19]. Therefore, the HF range was 0.07–1.0 Hz. The LF and HF
were estimated in standard normalized units (n.u.) to allow the comparison between the measurements
and patients.
Statistical analyses—Statistical analyses and graphical representations were performed in SPSS
(IBM®-SPSS Inc., Chicago, IL, USA, Version 22.0) and Microsoft® Excel (2010, Microsoft Corporation,
Redmond, DC, USA). The normality of data distribution was verified with the Kolmogorov-Smirnov
test. As the data were normally distributed, results were reported as mean and standard deviation
(SD). Analyses of variance (ANOVA) tests were done first to assess the overall effect over time and
between groups. Subsequently for multiple comparisons analyses using the Bonferroni correction were
used. Furthermore, two-tailed Pearson correlation coefficients was calculated to assess the association
between the HRV parameters and the HR, PCV, plasma lactate concentrations, and serum cortisol
concentrations. The statistical significance level was established as p ≤ 0.05 as significant, p ≤ 0.01 as
highly significant, and p ≤ 0.001 as most significant.
3. Results
3.1. Horses
The study population (n = 43) consisted of 19 mares, 23 geldings and 1 stallion. The breeds included
30 Warmbloods, 3 Haflinger horses, 3 Arabians, 2 Quarter horses, 1 Standardbred, 1 Frisian horse,
and 1 Cold blooded horse. Ages of the horses ranged between 3 and 29 years (mean = 12 ± 6 years).
Weight ranged between 250 and 680 kg (mean = 519± 88 kg) and height ranged between 144 and 178 cm
(mean = 165 cm ± 9 cm). The demographic data for each group are summarized in Table 1. There was
no statistically significant difference between the groups regarding age (p = 0.232), weight (p = 0.590)
or height (p = 0.452).
Several horses had received treatments before referral and used drugs included
Flunixin-Meglumine (9/43), Metamizole (16/43), Butylscopolamine (7/43), Xylazine (6/43) and
Butorphanol (4/43). One of the horses (1/43) was treated with Flunixin-Meglumine (1.1 mg/kg
every 8 h), Amoxicillin (10 mg/kg every 12 h and Gentamicin (6.6 mg/kg every 24 h for reasons
unrelated to colic.
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Table 1. Demographic data of the study population, including age, sex, breed, weight and height, and
athletic use of the horses in each treatment group.












(n = 11) 12 ± 6 4/6/1 9/1/0/0 506 ± 69 165 ± 9 1/2/3/5
2
(n = 24) 12 ± 6 9/15/0 15/7/1/1 532 ± 84 165 ± 9 1/0/14/9
3
(n = 8) 16 ± 7 6/2/0 5/2/1/0 500 ± 124 159 ± 18 1/1/6/0
all
(n = 43) 12 ± 6 19/23/1 30/10/2/1 519 ± 88 164 ± 11 3/3/23/14
* m, mare/g, gelding/s, stallion; ** others: 3 Arabian, 3 Haflinger, 2 Quarter horses, 1 Frisian horse, 1 standardbred.
*** b, breeding/l, leisure/p, paddock/s, sport (dressage, show jumping, western); hh, heavy horse; Kg, Kilogram; 2x;
SD, standard deviation; wb, warmblood; y, years.
Routine treatment protocol in the post-operative period consisted of administration of Flunixin-
Meglumine 1.1 mg/kg every 8 h, Amoxicillin 10 mg/kg every 12 h, Gentamicin 6.6 mg/kg every 24 h,
Ringer Lactate (varying amount to cover maintenance and eventual deficits) and Lidocaine (3 mg/kg/h,
bolus followed by CRI at 0.05 mg/kg/min, for 48 h or until cessation of reflux), and Heparin (120 IE/kg
every 12 h). The exact regime varied depending on the intraoperative diagnosis and intervention
(i.e., resection performed or not), on the clinical signs present, and the clinician’s assessment. Five horses
additionally received Sulfadiazin-Trimethoprim (30 mg/kg every 12 h) and Meloxicam (0.6 mg/kg
every 24 h) due to wound healing complications or Sulfadiazin-Trimethoprim (30 mg/kg every 12 h)
and Heparin (80 IE/kg every 24 h) due to peri-/thrombophlebitis.
3.2. HRV Analyses
The results of the HRV parameters are presented in Tables 2 and 3. The meanNN increased over
time in group 1 and 2 in the time domain analyses, however reached significant levels only in group 1 at
T3. These changes in meanNN translated into a significantly decreasing HR in both groups. In group 3,
however, there was no significant change over time. Furthermore, the meanNN and HR differed
significantly in group 3 compared to the other two groups at T2. At T1, group 3 showed significantly
different values than group 2, whereas the difference between group 1 and 3 was less evident at T1.
The most visible changes over time in the frequency domain analysis, occurred in group 1, whereas the
largest difference between groups was seen at T1, where group 2 showed a significant difference to
group 1 and 3. Therefore, there was a significant evolution over time in the HRV parameters in horses
that were discharged (Group 1 and 2) but not in the group 3 representing the non-survivors.
Table 2. Heart rate variability (HRV) parameters in the time domain analysis at the three measurement
time points (T1, T2, and T3) and in the three treatment groups.
T1 T2 T3


















(n = 11) <0.001
T1-T2: 0.001
T1-T3: <0.001




(n = 10) 0.003
T1-T2: 0.004
T1-T3: 0.042
3 67 ± 28(n = 8)
60 ± 20
(n = 4) - 0.680 -
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Table 2. Cont.
T1 T2 T3































(n = 11) 0.006 T1-T3: 0.005




(n = 10) 0.067 -
3 940.76 ± 328.11(n = 8)
969.73 ± 278.32
(n = 4) - 0.883 -
p-Value for the















(n = 11) 0.114 -




(n = 10) 0.479 -
3 56.14 ± 49.06(n = 8)
28.03 ± 23.55
(n = 4) - 0.311 -
p-Value for the











(n = 11) 0.622 -




(n = 10) 0.532 -
3 14.99 ± 23.31(n = 8)
4.95 ± 9.64
(n = 4) - 0.436 -
p-Value for the





- 1–3: 0.0352–3: 0.011 -
Bpm, beats per minute; HR, heart rate; meanNN; mean normal to normal R intervals, SD, standard deviation; SDNN,
the standard deviation of NN intervals; pNN50, percentage of consecutive R-R intervals that differed more than
50 ms. p values are indicated in italic
Table 3. HRV parameters in the frequency domain analyses at the three measurement time points (T1,
T2, and T3) and in the three treatment groups.
T1 T2 T3

















(n = 11) 0.002
T1-T2: 0.002
T2-T3: 0.049




(n = 10) 0.371 -
3 19.99 ± 14.74(n = 8)
36.20 ± 23.08
(n = 4) - 0.165 -
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Table 3. Cont.
T1 T2 T3












p-Value for the Overall





2–3: 0.047 - 1–2: 0.0231
LF (n.u.)




(n = 11) 0.002
T1-T2: 0.002
T2-T3: 0.049




(n = 10) 0.371 -
3 79.9 ± 15.0(n = 8)
63.80 ± 23.08
(n = 4) - 0.171 -
p-Value for the Overall





2–3: 0.050 - 1–2: 0.021
LF/HF




(n = 11) <0.001
T1-T2: <0.001
T1-T3: <0.001




(n = 10) 0.338 -
3 6.98 ± 5.93(n = 8)
3.68 ± 4.60
(n = 4) 0.355 -
p-Value for the Overall





2–3: 0.004 - -
HF, high-frequency ranges in the frequency domain analysis; LF, low-frequency ranges in the frequency domain
analysis; LF/HF, low-/high-frequency ratio; n.u., normalized units (n.u.) SD, standard deviation. p values are
indicated in italic.
3.3. Laboratory Variables
Serum cortisol concentrations also decreased over time in all groups, but the difference did not
reach statistical significance for group 3. They were significantly lower in group 2 in comparison
to group 1 and 3 at T1. However, the difference between group 2 and 3 was not significant at T2.
Plasma lactate values also decreased over time in all groups, and the difference between group 3 and
group 2 or 1 was significant at T1, as well as at T2 (Table 4).
Table 4. Laboratory variables at the three measurements time points (T1, T2, and T3) and in the three
treatment groups.
T1 T2 T3




















(n = 11) <0.001
T1-T3: <0.001
T2-T3: 0.013




(n = 10) 0.004
T1-T2: 0.014
T1-T3: 0.018
3 127.1 ± 67.9(n = 8)
71.9 ± 41.4
(n = 4) - 0.143 -.
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Table 4. Cont.
T1 T2 T3




















2–3: 0.023 1–2: 0.001 -
PCV
(%)




(n = 11) 0.075. -




(n = 10) 0.393 -
3 43 ± 18(n = 8)
36 ± 11
(n = 4) 0.445 -
p-Value for the





2–3: 0.042 -. -
TP
(g/dl)




(n = 10) 0.017 T1-T2: 0.022




(n = 10) 0.456 -.
3 5.6 ± 1.9(n = 7)
4.3 ± 1.1
(n = 4) 0.238. -.
p-Value for the

















(n = 10) 0.003
T1-T2: 0.014
T1-T3: 0.006




(n = 9) 0.019 T1-T2: 0.022
3 5.9 ± 5.3(n = 7)
2.1 ± 0.9
(n = 4) 0.205 -.
p-Value for the









SD, standard deviation. p values are indicated in italic.
3.4. Correlation
The two-tailed Pearson correlation revealed significant correlations between some of the HRV
parameters and PCV, plasma lactate, and serum cortisol values (Table 5). There was no significant
correlation between the TP and HRV parameters.
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Table 5. Correlation coefficients (r) with significances (p, p-value) between packed cell volume (PCV),
plasma lactate concentration, serum cortisol concentration, and the HRV parameters mean normal to
normal R intervals (meanNN), percentage of consecutive RR intervals that differed more than 50 ms
(pNN50), high-frequency (HF) ranges in the frequency domain analyses, low-frequency (LF) ranges in
the frequency domain analyses, and the low-/high-frequency ratio (LF/HF).
Parameter PCV Plasma Lactate MeanNN HF LF LF/HF
PCV
r 0.202 −0.406 −0.300 0.300 0.459
p 0.200 0.008 0.054 0.054 0.002
Plasma Lactate
r −0.537 −0.339 0.339 0.476
p <0.001 0.030 0.030 0.002
Serum Cortisol
r 0.542 0.361 0.396
p <0.001 0.019 0.010
4. Discussion
The main conclusion of this study is that the HRV measurements on the short-time ECG (5 min
sequences) can be accomplished in horses with colic and that the changes in the HRV parameters and
serum cortisol concentrations showed a decreased sympathetic simulation with treatment. This was
particularly visible in the increased meanNN and the HF power over time in the groups surviving to
discharge. Furthermore, it was visible that the meanNN was the only variable of the time domain
analysis that changed significantly over time and between groups, whereas the other variables of the
time domain analyses did not add any further information. The SDNN, especially, did not appear to
be a useful variable in our research question. Similarly, the European Task Force concluded that the
SDNN was a very imprecise variable for the characterization of HRV, especially for the short ECG
procedure, since the chronology of NN intervals is not included in the analysis, and a distinction
between the random changes and regular processes of the variability cannot be made [12]. However,
the meanNN paralleled the results of the HR and did not add further information about the HR in the
clinical assessment of the patient. Results in the frequency domain analyses were similar to the time
domain analyses at time point T1 and T2 but not at T3. The advantage of the frequency domain analysis
is to generate information which cannot be obtained by the time domain parameters. The frequency
domain analyses in human medicine highlight the changes in the sympathovagal balance and allows
one to better distinguish between the sympathetic and parasympathetic activity [12]. However, in our
study, there was no obvious advantage of the frequency domain analysis over the time domain analysis,
as the evolution over time was less consistent, even if group 2 at T1 had significantly different values
than the other two groups for HF, LF, and for LF/HF.
The difficulties encountered in the interpretation of the results from the study presented were
mainly due to the many factors that might influence the HRV and that could not be standardized
further in our study. Firstly, all horses included in the study were premedicated with different drugs
and postsurgical treatments were not standardized. The drugs applied could, therefore, have influences
on the HRV. It can generally be assumed that the anti-inflammatory and sympatholytic agents increase
the HRV [19,22], whereas the vagal nerve-inhibiting agents decrease the HRV [22]. Many horses
were treated with analgesic drugs (Metamizole, Flunixin-meglumine, Butorphanol, or Xylazine)
and spasmolytic drugs (Butylscopolamine) by the referring veterinarians prior to admission to the
hospital. The drug elimination half-life (also the effect-time) of Metamizole [30], Flunixin [31,32],
and Butorphanol [33] last several hours; therefore, upon arrival to the hospital, the HRV was probably
influenced by the first two drugs, whereas the opioids had less effect on the HRV according to a
study in humans [34]. Xylazine is a short-active a2-agonist [35,36] with secondary vagolytic effects.
Due to the short-lasting effect of xylazine, this drug had probably few impacts on the HRV during
the first examination. Butylscopolamine is also a vagolytic drug and was used in nearly all horses
by the referring veterinarians. Butylscopolamine reduced the HF power in one equine study [37],
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whereas several other studies [38–40] in humans have shown that at a low dosages, muscarine receptor
blockers can paradoxically increase the vagal activity. However, Butylscopolamine is a short-acting [41]
drug, and it probably had no effect on the HRV at the time of admission.
Furthermore, the drugs used during the induction and maintenance of anesthesia on horses
in group 1, specifically Medetomidine, Ketamine, Diazepam, and Isoflurane, might also have had
a negative influence on the vagal activity [42]. However, the duration of the drug effects is also
short-lasting [33,43–45]; thus, these medications probably had no effect on the HRV at T2. At this
time point, the horses that had been to surgery were treated with Flunixin-meglumine (1.1 mg/kg,
IV, every 8 h), which also had a positive influence on the HRV and a long-lasting effect. Therefore,
Flunixin-meglumine might also have influenced the HRV parameters. The effect of Lidocaine, that was
given in horses in the group 1 and 3, on the HRV parameter is not well studied. It is a class 1b
antiarrhythmic drug and would probably have the same inhibiting effects on the vagal nerve as class
1c antiarrhythmic drugs (e.g., Fecainid or Propafenone). However, the HRV parameters could also
be influenced by the anti-inflammatory attributes of Lidocain [46]. Similarly, the influence of the
antibiotics on the HRV parameters remains unclear. Antibiotics (Penicillin 30.000 IU/kg, IV, every 6 h;
Gentamicin, 6.6 mg/kg, IV, every 24 h) were used to treat the surgical patients in groups 1 and 3 (at T2)
and the patients in group 1 with wound healing problems or thrombophlebitis (at T3). Horses with
thrombophlebitis were also treated with heparin, which probably has a positive influence on the
HRV due to its thrombolytic effect [47,48]. Furthermore, these two patients with thrombophlebitis
received Meloxicam, which increases the HRV because of its analgesic effect [19,22]. Even if the drugs
mentioned might have had some influence on the HRV, it was outside the scope of this study to assess
their effect.
Another important limitation of the study is the inhomogeneous age, sex, and breed of the horses.
However, according to Nagel et al., there was no difference in the HRV between warmbloods and
ponies [49]. The literature provides further controversial results on the influence of age or sex on the
HRV in animals. A study in horses has documented an influence of sex on the HRV parameters [50],
whereas some studies in dogs have not found any relationship between sex and HRV parameters [51,52].
The influence of age on HRV parameters in humans was linked to pulse rigidity that increased with
age [53]. In horses, conflicting results have been reported for the effect of age. In an older study, age was
found to have had a small but significant influence on the LF specters of the HRV parameters [50].
Lower vagal activity measured in the frequency domain analyses has, for example, been shown in foals
and yearlings in comparison to older horses [54–56]. By contrast, a newer study comparing horses
between 4 and 6 years of age and horses >22 years of ages found a higher HR and lower meanNN
in the older horses [57]. However, another study did not find any significant influence of age on the
HRV in horses [19]. Unfortunately, the training effect in the group of younger horses in many of these
studies might have influenced the results [54–57]. In the current study, all horses were adult (mean age
12 ± 6 years). Furthermore, even if horses in group 3 seemed to be older, there was no statistically
significant difference between the groups, and, therefore, age would be expected to have had relatively
little influence on our population. Lastly, the temperament of the horses will certainly have had an
influence on the HRV [58–61] but could not be assessed in the current study.
Concerning environmental factors, it is known that the HRV has a diurnal rhythm [56,60,62],
and, therefore, the recordings at T2 and T3 were done in the morning. The examination environment,
however, was not ideal. Upon arrival (T1), the horses were examined in the examination room,
directly after transportation, surrounded by many people, whereas the examinations at T2 and T3
were performed in quiet rooms with only two people being involved. The European Task Force
recommended a quiet surrounding during the admission examination to avoid such influences [12],
and this should certainly be applied in future studies. The feeding regime also changed between day 2
and day 3, when horses were starved on day 2 and fed on day 3; however, this should not influence the
HRV [63,64].
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However, the results of the HRV analyses paralleled the results of the cortisol concentration.
Furthermore, there was a positive correlation between cortisol concentrations and LF/HF. Higher cortisol
level was, therefore, associated with lower HF values, higher LF or both, indicating a reduced
parasympathetic activation, as it is expected in painful conditions. Similarly, PCV and plasma lactate
concentrations also correlated negatively with parameters of the HRV. Whereas PCV showed no
difference in the three groups or between the three time points, the plasma lactate concentrations
allowed to distinguish group 3 from the other two groups and T1 and T2. Both lactate and PCV are
parameters indicating the status of the circulatory volume and, therefore, are related to the severity of
fluid loss in the condition. Fluid loss is a powerful drive for stimulation of sympathetic system and is,
therefore, negatively related to the variation if the RR intervals or the HF power.
5. Conclusions
As there are so many factors that influence the HRV, it is essential to standardize the registration
environment, handling, and drugs applied as much as possible. However, even with this many
influencing factors present, we still could demonstrate that treatment induced a change in the
HRV and cortisol response in horses managed conservatively or surgically but not in horses that
required euthanasia. Furthermore, cortisol concentrations correlated positively with LF/HF. Therefore,
we concluded that the HRV can provide further important information on the stress level in horses
with colic and might be helpful in assessing possible outcome. However, further studies are required
to assess the validity of the HRV analyses in horses with colic. Another interesting finding was
that plasma lactate was the only variable that constantly differed in group 3 from group 1 and 2,
underscoring the importance of evaluating plasma lactate in the assessment of the severity of diseases
in horses with colic [9,10].
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